History and Physical Template for Infectious Disease Evaluation
For infectious disease consultations, structure your H&P to systematically capture exposure history, immune status, and infection-specific clinical features while documenting elements that guide antimicrobial stewardship and prognostic assessment.
Chief Complaint and History of Present Illness
Document the following systematically:
Symptom onset and timeline: Exact dates of symptom onset, fever patterns (continuous vs intermittent), and progression
Fever characteristics: Maximum temperature, timing, associated rigors or night sweats
Localizing symptoms:
- Respiratory: cough (productive vs dry), sputum character, dyspnea, pleuritic pain
- Genitourinary: dysuria, frequency, flank pain, discharge
- Gastrointestinal: diarrhea (bloody vs watery), abdominal pain, nausea/vomiting
- Neurologic: headache, altered mental status, focal deficits, photophobia
- Skin/soft tissue: rash distribution and character, wound characteristics, pain out of proportion
Severity indicators: Confusion, hypotension, tachypnea >20/min, tachycardia >90/min, temperature >38°C or <36°C 1
Infectious Disease-Specific History
Exposure and Epidemiologic Risk Factors
Travel history 2:
- Countries/regions visited with specific dates
- Dates of symptom onset relative to travel
- Malaria prophylaxis use and adherence
- Freshwater exposure, animal contacts, insect bites
- Food and water sources
Occupational/environmental exposures 3, 4:
- Farming, animal handling (specify species)
- Bird exposure (type, duration, intensity)
- Water damage, mold, air conditioning systems
- Healthcare work, laboratory exposure
- Homeless shelter, correctional facility
Sexual and substance use history 5:
- Number and gender of partners
- Condom use patterns
- Receptive oral, vaginal, or anal intercourse
- Injection drug use: needle sharing, last use
- Genitourinary symptoms or discharge
- Partner STD history
Contact history:
- Sick contacts with similar symptoms
- Household members with infections
- Recent hospitalization or healthcare facility exposure
- Tuberculosis exposure and prior TST results 5
Past Medical History - Infection Risk Stratification
Immunocompromising conditions 5:
- HIV status: CD4 count (current and nadir), viral load, ART regimen and adherence
- Solid organ or hematopoietic stem cell transplant
- Active malignancy or chemotherapy
- Immunosuppressive medications (corticosteroids, biologics, DMARDs)
- Diabetes mellitus, chronic liver disease, chronic kidney disease
- Asplenia (functional or anatomic)
Chronic conditions affecting infection risk 1, 3:
- COPD, bronchiectasis
- Cardiovascular disease
- Neurologic disease with aspiration risk
- Peripheral vascular disease, neuropathy
- Chronic wounds or ulcers
Prior infections 5:
- Previous opportunistic infections with dates
- Recurrent infections (UTI, pneumonia, cellulitis)
- Prior positive cultures and resistance patterns
- History of C. difficile infection
- Latent TB infection and treatment
Antibiotic and Medication History
- Current and recent antibiotics (within 3 months): specific agents, doses, duration, response 1
- Antiretroviral therapy: regimen, adherence, prior regimens, resistance testing results 5
- Immunosuppressive medications: doses and duration
- Prophylactic antimicrobials: PCP, MAC, fungal prophylaxis
- Drug allergies: specific reactions (distinguish true allergy from intolerance) 5
- Over-the-counter and herbal supplements: potential drug interactions 5
Vaccination History 5
- Pneumococcal (PCV13, PPSV23)
- Influenza (current season)
- Hepatitis A and B
- Tetanus/diphtheria
- COVID-19
- Others relevant to travel or exposure
Social History 5
- Living situation: alone, group home, nursing facility
- Tobacco use (pack-years)
- Alcohol use (quantify)
- Recreational drug use
- Recent incarceration
- Homelessness
- Pets and animal exposures
Physical Examination
Vital Signs and General Appearance
- Temperature, heart rate, respiratory rate, blood pressure, oxygen saturation
- Appearance: toxic vs well-appearing, distress level
- Mental status: alert, confused, lethargic
Systematic Examination for Infection
Skin and lymph nodes:
- Rash: distribution (diffuse, localized), morphology (macular, papular, vesicular, petechial)
- Eschars or ulcers
- Injection sites or track marks
- Lymphadenopathy: location, size, tenderness, fluctuance
- Jaundice
Head and neck:
- Oral lesions: thrush, ulcers, Kaposi sarcoma
- Pharyngeal erythema or exudate
- Sinus tenderness
- Nuchal rigidity
Cardiovascular:
- New murmur (endocarditis)
- Peripheral stigmata of endocarditis (Osler nodes, Janeway lesions, splinter hemorrhages)
Pulmonary:
- Crackles, wheezes, bronchial breath sounds
- Dullness to percussion (effusion)
- Egophony
Abdominal:
- Hepatosplenomegaly
- Right upper quadrant tenderness
- Peritoneal signs
- Costovertebral angle tenderness
Genitourinary:
- Genital lesions or discharge
- Testicular or prostatic tenderness
Musculoskeletal:
- Joint effusion, erythema, warmth, range of motion
- Vertebral tenderness
- Extremity edema or erythema
Neurologic:
- Focal deficits
- Cranial nerve abnormalities
- Meningeal signs
Assessment and Severity Stratification
Document Infection Severity Classification
For diabetic foot infections 1:
- Grade 1: Uninfected
- Grade 2: Mild (erythema 0.5-2 cm, skin/subcutaneous only)
- Grade 3: Moderate (erythema >2 cm or deeper structures, no SIRS)
- Grade 4: Severe (SIRS present: temp >38°C or <36°C, HR >90, RR >20, WBC >12,000 or <4,000)
- Risk factors requiring hospitalization: age >65, altered mental status, respiratory rate >30, hypotension, multilobar involvement
Differential Diagnosis
List in order of likelihood based on:
- Clinical syndrome
- Exposure history
- Host factors
- Local epidemiology
Plan
Diagnostic Studies Ordered
- Cultures (blood, urine, respiratory, wound) with timing relative to antibiotics
- Imaging with specific indication
- Serologies or molecular testing
- Invasive procedures planned
Antimicrobial Therapy
- Empiric regimen with rationale
- Planned duration
- Stewardship considerations (de-escalation plan, biomarkers for stopping)
Infection Control Precautions
- Isolation type if indicated
- Public health notification requirements
Follow-up and Monitoring
- Clinical response parameters
- Laboratory monitoring
- Repeat imaging timing
Key Documentation Pitfalls to Avoid:
- Failing to document exact travel dates and locations for febrile returned travelers 2
- Not specifying CD4 count and viral load in HIV patients 5
- Omitting antibiotic exposure within past 3 months when assessing resistance risk 1, 3
- Inadequate sexual history limiting STD screening appropriateness 5
- Missing SIRS criteria documentation that determines infection severity 1